Venrock is a Palo Alto-based venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It concentrates on seed and early-stage investments in technology and healthcare, with interests spanning information technology, life sciences and related sectors in the United States. The firm has supported a broad portfolio of companies, including Apple, Intel, Illumina, DoubleClick, Athenahealth, Gilead Sciences, Nest, SlideShare and Tudou. Venrock emphasizes long-term partnerships with entrepreneurs, combining hands-on venture support with rigorous data analysis to help startups grow into enduring companies.
Avadel Pharmaceuticals is a specialty pharmaceutical company focused on developing and marketing differentiated drug products. It operates internationally with headquarters in Dublin and a presence in St. Louis and Lyon. The portfolio centers on urology, central nervous system/sleep, and hospital products, including LUMRYZ, an extended-release formulation of sodium oxybate for narcolepsy-related cataplexy and excessive daytime sleepiness in adults. The company markets three sterile injectable medicines for hospital use: Akovaz for hypotension during anesthesia, Bloxiverz for reversal of non-depolarizing neuromuscular blocking agents after surgery, and Vazculep for treatment of hypotension. Avadel pursues new product development through formulation innovation and partnerships to improve patient adherence and outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.